Logo image of IINN

INSPIRA TECHNOLOGIES OXY BHN (IINN) Stock Fundamental Analysis

NASDAQ:IINN - IL0011715781 - Common Stock

1.14 USD
-0.03 (-2.56%)
Last: 8/25/2025, 8:00:02 PM
1.14 USD
0 (0%)
Pre-Market: 8/26/2025, 5:36:14 AM
Fundamental Rating

2

Taking everything into account, IINN scores 2 out of 10 in our fundamental rating. IINN was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of IINN is average, but there are quite some concerns on its profitability. IINN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IINN had negative earnings in the past year.
In the past year IINN has reported a negative cash flow from operations.
In the past 5 years IINN always reported negative net income.
IINN had a negative operating cash flow in each of the past 5 years.
IINN Yearly Net Income VS EBIT VS OCF VS FCFIINN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

IINN has a worse Return On Assets (-136.96%) than 86.49% of its industry peers.
The Return On Equity of IINN (-255.74%) is worse than 76.76% of its industry peers.
Industry RankSector Rank
ROA -136.96%
ROE -255.74%
ROIC N/A
ROA(3y)-107.44%
ROA(5y)-223.64%
ROE(3y)-177.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IINN Yearly ROA, ROE, ROICIINN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

IINN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IINN Yearly Profit, Operating, Gross MarginsIINN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

IINN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IINN has more shares outstanding
There is no outstanding debt for IINN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IINN Yearly Shares OutstandingIINN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IINN Yearly Total Debt VS Total AssetsIINN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

IINN has an Altman-Z score of -10.97. This is a bad value and indicates that IINN is not financially healthy and even has some risk of bankruptcy.
IINN's Altman-Z score of -10.97 is on the low side compared to the rest of the industry. IINN is outperformed by 81.08% of its industry peers.
There is no outstanding debt for IINN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.97
ROIC/WACCN/A
WACCN/A
IINN Yearly LT Debt VS Equity VS FCFIINN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 2.02 indicates that IINN has no problem at all paying its short term obligations.
IINN has a Current ratio of 2.02. This is in the lower half of the industry: IINN underperforms 63.24% of its industry peers.
IINN has a Quick Ratio of 1.89. This is a normal value and indicates that IINN is financially healthy and should not expect problems in meeting its short term obligations.
IINN has a Quick ratio of 1.89. This is comparable to the rest of the industry: IINN outperforms 50.81% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.89
IINN Yearly Current Assets VS Current LiabilitesIINN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

IINN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.02%, which is quite impressive.
EPS 1Y (TTM)36.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

IINN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.70% yearly.
IINN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 159.60% yearly.
EPS Next Y47.14%
EPS Next 2Y34.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-68.65%
Revenue Next 2Y159.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

IINN Yearly Revenue VS EstimatesIINN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 5M 10M 15M 20M
IINN Yearly EPS VS EstimatesIINN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IINN. In the last year negative earnings were reported.
Also next year IINN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IINN Price Earnings VS Forward Price EarningsIINN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IINN Per share dataIINN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

IINN's earnings are expected to grow with 34.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.7%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IINN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIRA TECHNOLOGIES OXY BHN

NASDAQ:IINN (8/25/2025, 8:00:02 PM)

Premarket: 1.14 0 (0%)

1.14

-0.03 (-2.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2025-03-11
Earnings (Next)N/A N/A
Inst Owners5.17%
Inst Owner Change-57.55%
Ins Owners8.75%
Ins Owner ChangeN/A
Market Cap29.21M
Analysts82.86
Price Target3.06 (168.42%)
Short Float %1.64%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-76.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.63%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)900%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.76
P/tB 6.76
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.96%
ROE -255.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-107.44%
ROA(5y)-223.64%
ROE(3y)-177.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 95.91%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.89
Altman-Z -10.97
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)121.61%
Cap/Depr(5y)89.97%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.55%
EPS Next Y47.14%
EPS Next 2Y34.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-68.65%
Revenue Next 2Y159.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.92%
OCF growth 3YN/A
OCF growth 5YN/A